The inherent heterogeneity of bone cells complicates the interpretation of microarray studies designed to identify genes highly associated with osteoblast differentiation. To overcome this problem, we have utilized Col1a1 promoter-green fluorescent protein transgenic mouse lines to isolate bone cells at distinct stages of osteoprogenitor maturation. Comparison of gene expression patterns from unsorted or isolated sorted bone cell populations at days 7 and 17 of calvarial cultures revealed an increased specificity regarding which genes are selectively expressed in a subset of bone cell types during differentiation. Furthermore, distinctly different patterns of gene expression associated with major signaling pathways (Igf1, Bmp, and Wnt) were observed at different levels of maturation. Some of our data differ from current models of osteoprogenitor cell differentiation and emphasize components of the pathways that were not revealed in studies based on a total cell population. Thus, applying methods to generate more homogeneous populations of cells at a defined level of cellular differentiation from a primary osteogenic culture is feasible and leads to a novel interpretation of the gene expression associated with increasing levels of osteoprogenitor maturation.
The inherent heterogeneity of bone cells complicates the interpretation of microarray studies designed to identify genes highly associated with osteoblast differentiation. To overcome this problem, we have utilized Col1a1 promoter-green fluorescent protein transgenic mouse lines to isolate bone cells at distinct stages of osteoprogenitor maturation. Comparison of gene expression patterns from unsorted or isolated sorted bone cell populations at days 7 and 17 of calvarial cultures revealed an increased specificity regarding which genes are selectively expressed in a subset of bone cell types during differentiation. Furthermore, distinctly different patterns of gene expression associated with major signaling pathways (Igf1, Bmp, and Wnt) were observed at different levels of maturation. Some of our data differ from current models of osteoprogenitor cell differentiation and emphasize components of the pathways that were not revealed in studies based on a total cell population. Thus, applying methods to generate more homogeneous populations of cells at a defined level of cellular differentiation from a primary osteogenic culture is feasible and leads to a novel interpretation of the gene expression associated with increasing levels of osteoprogenitor maturation.
Identification of genes that are associated with the onset of osteoblast differentiation or control the progression of osteoprogenitor cells has been largely based on culture models that involve osteogenic inducers (1, 2) . The acute response to the addition of bone morphogenetic protein (BMP) 1 has been used in a number of immortalized cell lines, and the lineage progression to osteogenic nodule formation has been studied in primary murine, rat, and human cultures when grown in the presence of ascorbic acid, ␤-glycerophosphate, and dexamethasone. From these studies, a generalized pattern of diminished cell proliferation followed by an increase in the expression of genes associated with bone matrix production has been observed. Progression of differentiation has also been associated with the suppression of genes that are required for differentiation into other cell lineages, including myocyte and adipocyte lineages (3) (4) (5) (6) . Several studies highlight the complexity of using mesenchymal stem cells to identify genes associated with bone cell lineage progression and commitment (3-7). The major reason for this has to do with the limited number of cells within the culture that become mature osteoblasts, thereby representing only a small proportion of the total population. Therefore, when changes in gene expression are observed, it is never certain whether these changes occur in fully differentiated osteoblasts or other cell populations (7) .
The heterogeneity of a primary bone cell culture can be appreciated when different promoter-GFP reporter constructs are used as visual surrogates for osteoblast differentiation. We have previously presented evidence that the GFP driven by a 3.6-kb Col1a1 promoter fragment (pOBCol3.6GFP, referred to as 3.6GFP) becomes visible when alkaline phosphatase-positive cell colonies are detected 5-7 days before the colonies develop into mineralizing multilayered nodules. In contrast, a 2.3-kb Col1a1 promoter fragment driving GFP (pOBCol2.3GFP, referred to as 2.3GFP) remains inactive until the nodules begin to mineralize (8) . Based on these expression patterns we have associated the early expression of the 3.6GFP with cells reaching the preosteoblast level of differentiation, which continues during early osteoblast development, whereas the 2.3GFP expression represents a cell that has acquired the ability to form a mineralized matrix. Because the 2.3GFP-positive cells represent less than 15% of the total cell population of a well mineralized osteoblast culture, it is likely that a microarray study based on a heterogeneous cell mixture would not accurately represent the expression of a fully differentiated osteoblast (8) .
This study was designed to contrast the pattern of gene expression of a mixed cell population with one in which two populations from the same sample are isolated based on their stage of differentiation. Mouse calvarial cultures at days 7 and 17 underwent microarray analysis either as a total cell population or as cells separated based on GFP expression. This study demonstrates the importance of using defined and rela-tively homogeneous cell populations to more completely understand the gene expression profile of cells at a particular stage of development.
MATERIALS AND METHODS
Cell Culture-Transgenic mice used in this study have been generated and characterized previously (8) . Mouse calvarial osteoblast (mCOB) cells were isolated from 6 -9-day-old transgenic mice by sequential 0.05% trypsin/collagenase digestions as described previously (8) . Cells were plated at a density of 1.5 ϫ 10 4 cells/cm 2 , and at 1 week of culture, differentiation was induced with 50 g/ml ascorbic acid and 4 mM ␤-glycerophosphate.
Preparation of Cells for Sorting-7-Day-old cultures were digested using 0.25% trypsin, 1 mM EDTA for 5-10 min. Trypsin was inactivated by addition of DMEM, 10% FCS followed by centrifugation at ϩ4°C. Cells were resuspended in phosphate-buffered saline and filtered using a 70-m strainer. Following a second centrifugation cells were resuspended in phosphate-buffered saline, 2% FCS and filtered through a 45-m filter. Cells grown for 17 days were digested using a 0.2% collagenase, 0.2% hyalouronidase, 2.5% trypsin. Enzymes were neutralized using DMEM, 10% FCS, and cells were centrifuged and prepared as described above. Cell sorting was done on a FACS Vantage (BD Biosciences) with excitation at 488 nm and 530/30 emission filter. Cells were separated using a 100-m nozzle and collected into DMEM, 30% FCS media. Prior, during, and following sorting the cell suspensions were kept cold to minimize changes in gene expression.
RNA Extraction and Northern Blot Analysis-RNA was extracted using a TRIzol LS reagent (Invitrogen) according to the manufacturer's instructions, and Northern blots were prepared using procedures described previously (8) . Membranes were probed with the following fragments: 0.7 kb of GFP, 0.7 kb of EcoRI Igf1 (9), 900 bp of PstI rat Col1a1 (p␣1R2), (10) , 440 bp of PstI/EcoRI mouse Bglap1 (p923), (11) , 0.7 kb of Dmp1 (12) , and 1000 bp of EcoRI mouse Ibsp (13) . Probes were radiolabeled, and hybridization was performed using the protocols described previously (8, 14) .
Array Hybridization and Data Analysis-The cRNA preparation and array hybridization were performed according to the Affymetrix protocol (Affymetrix, Santa Clara, CA). Briefly, cRNA was prepared from 10 g of total RNA. The RNA was denatured at 70°C with T7-tagged oligo(dT) primers and then reverse transcribed with Superscript II (Invitrogen) at 42°C for 1 h. Second-strand cDNA was synthesized by adding DNA polymerase I, Escherichia coli DNA ligase, and RNase H, and incubation was carried out for 2 h at 16°C. After phenol/chloroform extraction, the synthesized cDNA was used for in vitro transcription using the BioArray high yield RNA transcript labeling kit (Enzo Life Sciences, New York, NY). Labeled cRNA was purified with RNeasy columns (Qiagen) and fragmented before hybridization (10 g/chip).
Affymetrix murine U74A, -B, and -C v2 oligo array cartridges were prehybridized at 45°C for 10 min and hybridized for 16 h at 45°C with 60 rpm rotation. After hybridization, the chips were washed and stained in a fluidics station using the antibody amplification protocol from Affymetrix and scanned using a Hewlett-Packard GeneArray scanner. The data were analyzed using GeneChip software MAS4 (Affymetrix). An intensity value and presence/absence call was derived from the hybridization signal for each gene to represent its expression level. Data were normalized with the slope of hybridization intensity of a control sample before comparison. The annotations of Affymetrix chip probe sets were derived from NetAffx (Affymetrix).
We applied two statistical methods to select differentially expressed genes. 1) Significance analysis of microarrays (SAM) orders the genes by using the modified t statistic and declares a gene to be up-regulated (down-regulated) if the observed modified t statistic is above (below) the global cutoff point (15) . This procedure allows estimation of the median of false discovery rates. In this study we selected the cutoff points to control this median to be at most 5%.
2) The semiparametric hierarchical (SPH) mixture model was developed by Newton et al. (16) to capture the complicated variations observed in microarray data. According to this method, we first estimated the shape parameter in the ␥ distribution by the moment method. Then we fit the mixture model by a nonparametric expectation and maximization algorithm. Posterior probabilities for the three hypotheses (un-regulated, up-regulated, down-regulated) were computed numerically for each gene. We ranked the genes according to the posterior probabilities for a hypothesis. To determine the cutoff point, a SPH mixture model controlled the false discovery rate (FDR) from the posterior probabilities. The expected FDR was computed by averaging mistake probabilities from the top to subsequent ones. The cutoff gene was selected when the expected FDR reached at most 5%.
RESULTS

Isolation of the GFP-positive (GFP pos ) and GFP-negative (GFP neg ) Cells from Primary Calvarial Culture
Cultures were established from GFP transgenic mice, and the onset of GFP expression during the osteoblast differentiation was obtained by fluorescent imaging. The 3.6GFP signal activates between day 4 and day 7 of culture ( Fig. 1A) in forming colonies and associates with the onset of alkaline phosphatase staining (data not shown). The majority of these colonies will develop into bone nodules. Cells lacking the GFP signal are more prevalent at the periphery and between the developing colonies. At this time, FACS analysis shows that ϳ30 -40% of cells express the 3.6GFP transgene (Fig. 1C) . Following induction of osteogenic differentiation (day 7), the culture develops multilayered nodules that will mineralize. By day 15-17 of culture, Ibsp and Bglap1, molecular markers of mature osteoblast differentiation, are expressed. At this time, about 10% of cells within the culture express the 2.3GFP transgene (Fig. 1, B and E), and these cells are restricted to the mineralizing nodules (Fig. 1B, arrows) . GFP pos and GFP neg cells were separated by flow cytometry. FACS reanalysis was carried out on isolated cell populations demonstrating that the sorting process highly enriched GFP pos and GFP neg populations. For 3.6GFP, the percentage of positive cells increased from 30 to Ͼ97%, whereas 2.3GFP increased from 10 to Ͼ85% (Fig. 1, C-F) .
Prior to microarray analysis, Northern blot analysis was performed to verify the effectiveness of the sorting process and the quality of the RNA. Fig. 2 
Gene Expression by Microarray Analysis
Seven-day-old cultures were harvested to obtain 3.6GFP pos and GFP neg (at the preosteoblastic stage), and 17-day-old cultures were used to isolate 2.3GFP GFP pos and GFP neg cells at the mature osteoblast stage. The entire process of cell culture, FACS sorting, RNA extraction, probe labeling, and microarray hybridization was performed three times, and the results were analyzed as three replicates. The 74A chip was used to compare the expression profile of the FACS-separated cells with the parental total cell population taken at day 7 and day 17 of culture.
3.6GFP pos Versus GFP neg Cells
The two populations of cells were isolated from a 7-day-old culture for RNA extraction. No genes showed higher expression in 3.6GFP pos when compared with GFP neg cells. However, 69 genes showed significant decrease in expression by one or both of the statistical tests, SAM and the SPH mixture model (genes listed in Tables I and II) . When genes with lower expression were grouped based on similar decrease in expression in unsorted day 7 to day 17 cell populations, 11 genes were identified, all of which are associated with smooth muscle cells or pericytes (Table I ). This type of result has been observed in other microarray studies that use total cell populations (7) and provides supportive evidence that the sorting process separates bone progenitor cells from other cell types that have lost these progenitor cell markers. The remainder of genes with lower expression in the 3.6GFP pos cells showed an increase in expression as the total cell population moved from day 7 to day 17. Many of these genes encode proteins that modify or interact with the extracellular space or are involved in cytokine signaling. A number of genes are associated with dendritic cells or cells within the macrophage/osteoclast lineage (Table II) . Of particular interest are Tyrobp, which is a RANKL adaptor molecule that displays the osteopetrotic phenotype when disrupted (17) , and the Csf1 receptor. This latter group of genes may reflect a population of monocyte/osteoclast progenitor cells that continues to increase in number and level of differentiation explaining their increased expression in day 17 culture. However, their fall in expression in the 3.6GFP
pos cells suggests that these cells do not directly contribute to the osteoblast lineage. Table 1 ). Similarly, a number of known osteoblast differentiation-regulated genes such as transcription factor distal-less homeobox 3 (Dlx3), dentin matrix protein 1 (Dmp1), dickkopf homolog 1 (Dkk1), parathyroid hormone receptor 1 (Pthr1), prostaglandin I2 synthase (Ptgis), and phosphate-regulating neutral endopeptidases (Phex) were also found in this category. Interestingly, a few genes with currently no appreciated role in bone biology, such as hepatic lipase (Lipc), bone morphogenetic protein 8a (Bmp8a), leuke- neg population, the change in which is not shown by the total cell population analysis (Table III) . A role for many of these genes in this osteoblast function is not obvious, and confirmation of their importance will require gene deletion studies. For example, mice with a total deficiency of the Cpe gene are obese, although no analysis of the bone phenotype has been made. Other genes include an ion transfer gene (chloride channel 3) and cationic amino acid transporter, genes involved in cell metabolic activity (stearoyl-coenzyme A desaturase 1, cytochrome-c oxidase subunit VIa, asparaginase synthetase), a cytoskeletal gene (ankyrin 3 epithelial), and two transcription regulation factors (Fyn proto-oncogene and Kruppel-like factor 4). The increased expression of farnesyl pyrophosphate synthetase and fatty acid-binding protein 3 is noteworthy because of the beneficial effect of statins on bone mass (18, 19) .
Group C: Genes That Have Lower Expression in Unsorted (Day 17 Versus Day 7) Cultures as Well as in Sorted Mature
Osteoblasts-Lower gene expression with increasing cell differentiation likely reflects the loss of progenitor potential and the restriction of the synthetic capacity of the genes characteristic of the differentiated cell type (supplemental Table 2 ). Thus, observing many genes that decrease in expression during osteoblastic differentiation is not unexpected in either the unsorted or 2.3GFP pos -sorted cell population. Msx2, a transcriptional factor with importance in early osteoblastogenesis is a gene with a known reduction in expression during differentiation. Other genes that are suppressed but have roles in the osteogenic lineage that are less recognized include fibulin 2, necdin, cysteine-rich protein 2, and inhibin ␤-B.
Group D: Genes with Unchanged or Higher Expression Levels in Unsorted Differentiating Cultures (Day 17 Versus Day 7) That Show Significantly Lower Expression in Sorted Mature
Osteoblasts-The heterogeneity of osteoblastic culture is evident in genes that show either no change or higher expression in unsorted cultures from day 7 to day 17, when in fact their expression is lower in the isolated 2.3GFP pos cell population (Tables IV and V) . Examples include extracellular matrix genes more associated with non-osseous tissues such as procollagen IVa1 (endothelium), matrix Gla protein (smooth muscle cells and chondrocyte lineage cells), fibulin 1 (elastic tissue), thrombospondin and tissue inhibitor of metalloproteinase 2 (wound repair), intracellular adhesion molecule 1 (ICAM1) (endothelial), Meox2 (muscle), Mest (kidney), and osteoglycin (cartilage). This suggests that the 2.3GFP pos cell population is distinguishing itself from a heterogeneous and less differentiated cell population (2.3GFP neg ). However, other growth factors sometimes associated with osteoblast differentiation also show lower expression. Included in this category are fibroblast growth factor 7 and two Igf-binding proteins known to affect bone mass. More surprisingly, a group of genes that shows higher expression in the unsorted population is expressed at a lower level in the 2.3GFP pos population (Table V) . The most striking examples in this group are genes that have been described as up-regulated with osteoblast differentiation such as Igf1, stromal cell-derived factor 1, prostaglandin E4 receptor, and follistatin. Other genes in this group represent a number of cell membrane and extracellular matrix genes unassociated with osteoblasts including lipoprotein lipase, apolipoprotein D, embigin, matrillin 4, and microfibrillar associated protein 2 (Tables IV and V) .
Expression of Genes Associated with the Igf, Bmp, and Wnt Signaling Pathways in Sorted Cells at Four Levels of Differentiation
Osteoblast differentiation is regulated by a number of systemic hormones and local factors that induce different signaling pathways in cells within the osteoprogenitor lineage. Major pathways that are known to modulate bone mass by affecting the number or activity of osteoblasts include Igf, Bmp/Smads, and Wnt. Because it is assumed that these pathways are stimulated or inhibited at different levels of cellular development within the osteoprogenitor lineage, we examined the expression of a number of these genes in the four populations of FACS-isolated cells.
Insulin-like Growth Factor 1 and 2 Pathways-Previous studies have associated deficiencies of Igf1 or the Igf1 receptor in osteoblasts with low bone mass and retarded bone cell differentiation, and four of the Igf-binding proteins (-2, -3, -4 and -5) can modulate the availability of the Igf1 to its receptor in osteoblasts. Expression of the Igf1 receptor did not differ significantly between the four populations (Table VI) . However, expression levels of Igf1 are 5-fold lower in the 2.3GFP pos population relative to the negative population. Note that Igf1 expression increased in the unsorted populations providing another example of a paradoxical response in unsorted and sorted cell populations (Table V) . Also, Igf-binding proteins -2, -3, -4, and -5 showed 2-5-fold lower expression in the 2.3GFP pos versus the 2.3GFP neg population. In all cases, analysis of the unsorted population did not detect any changes in expression of these binding proteins. Thus, based on this analysis, most of the transcriptional activity affecting production of the Igf1 and pos population relative to the negative population. Analysis of the unsorted population shows no reduction in the expression during the maturation of the cultures from day 7 to day 17 providing another example where analysis of sorted cells reveals changes that are not apparent in unsorted cell populations (Table VII) .
Bone Morphogenetic Proteins-BMPs play an important role in osteogenesis during development and in adult life (20) . There were no major changes in the expression of Bmp genes or their antagonists between 3.6GFP neg and 3.6GFP pos , but with the transition from the 2.3GFP neg to the 2.3GFP pos stage a 6-fold higher expression of Bmp8a was observed (Table VIII) . Bmp2 also increased 2-fold, but this increase did not meet statistical significance. Other activators within this pathway including Bmp4, Bmp7, Bmp receptors, and Smad1 and Smad5 were constitutively expressed. The mature osteoblast population (2.3GFP pos ) exhibited a significant decrease in the Bmp antagonists follistatin, follistatin-like protein related to DAN and cerberus, and growth differentiation factor 10 (Table IX) . This decrease in follistatin gene expression in mature osteoblasts contradicts a recent report of an increase in follistatin in osteoblast cultures (21) . Countering this apparent loss of inhibitory proteins on the BMP pathway in the 2.3GFP pos cells was an increase in expression of the pseudoreceptor for the Bmp/ activin membrane-bound inhibitor (Bambi). Intracellular negative regulators of BMP signaling (Smad4, Smad6, and Smad7) did not show significant changes during differentiation. Our data are consistent with the potential of the mature osteoblast to induce neighboring less differentiated cells within the lineage by an increase in Bmp2 and Bmp8a expression and decrease in secreted inhibitors (Fls and Fls-like) . In contrast, terminally differentiated osteoblasts can restrict the effects of BMPs on themselves by expressing high levels of the Bambi pseudoreceptor.
Wnt Pathway-Several lines of evidence indicate essential roles for the Wnt canonical pathway in bone formation and maintenance. This pathway can be activated by a selected group of Wnt ligands that binds to a receptor complex consisting of the frizzled class of receptors and the low density lipoprotein receptor-related protein 5 or -6 (Lrp5, Lrp6) (22, 23) . As a result, protein levels of ␤-catenin increase allowing it to function as a transcriptional co-activator when it associates with members of the lymphoid-enhancing factor/T-cell factor family (24, 25) . Microarray expression studies of sorted bone cells derived from calvarial cultures reveal that a large number of genes associated with the Wnt pathways are expressed. Table X focuses on genes that have protein products that are responsible for Wnt pathway activation. Although small differences are observed in the 3.6GFP pos and 3.6GFP neg cell-sorted populations, 2.3GFP pos cell-sorted populations show higher expression of Wnt3a, Lrp5, and Tcf-1, and Wnt5a, Frizzled 1, and Frizzled 8 are expressed at lower levels. Our array studies included dishevelled 1 and 2, which are both expressed; however, dishevelled 1 expression is substantially higher than dishevelled 2, implying that it may be the predominant form expressed in bone cell types. ␤-Catenin, although highly expressed, shows no differences in expression levels at the tran- scriptional level in all bone cell-sorted populations. This is not surprising because ␤-catenin is post-transcriptionally regulated by the Wnt pathway and also functions in cell-cell adhesion complexes by associating with cadherins. Genes encoding inhibitors of the Wnt pathway are grouped in Table XI . Among these selected genes are members of the secreted frizzled-related protein (Sfrp3) and dickkopf (Dkk) families (26) . Interestingly, dickkopf homolog 1 and Sfrp3 are expressed at higher levels in Col2.3 pos cells, whereas Sfrp1 and Sfrp2 show higher expression in Col2.3 neg cell types. Although the significance of these expression differences remains to be determined, it is important to note previous work showing distinct biological properties among different Sfrp proteins (27) . Genes that encode for intracellular inhibitors of the Wnt canonical pathway, including casein kinase I␣, Gsk3␤, and axin, which functionally interact to mediate ␤-catenin degradation, show no significant changes in expression levels. Casein kinase I␣ and Gsk3␤ are ubiquitously expressed kinases that are post-transcriptionally regulated, and their functions are not exclusive to the Wnt pathway. Therefore, array studies showing no changes in their gene expression among sorted calvaria cells are not surprising.
DISCUSSION
This microarray study adds validity to the use of the Col1a1-GFP reporter constructs as markers of increasing maturation within the osteoblast lineage. The biological properties of the cells identified by the marker genes reflected an incremental increase in osteoblast differentiation that is supported by the present molecular studies of the isolated cell populations. The low-level 3.6GFP expression characteristic of the initial transition of a 3.6GFP neg to a 3.6GFP pos cell that is analyzed in the present study can be observed in periosteal fibroblasts and calvarial suture cells, known sites of preosteoblastic cells that will progress to full osteoblast differentiation (8, 28) . Our microarray data suggest the presence of a heterogeneous population of precursor cells composed in part of cells with a myofibroblast/pericyte phenotype and other types of cell with a myeloid/macrophage/osteoclast lineage phenotype. It is from this population that 3.6GFP pos cells emerge as a line that suppresses the markers of both cell types but has not yet acquired markers of a differentiated osteoblast. Thus, the microarray data suggest that a myofibroblast/pericyte present in the primary osteoblast culture acquires the 3.6GFP pos marker at the time it begins to enter the osteoblast lineage. During maturation of the culture, cells will begin to express the 2.3GFP pos marker and contribute to the mineralization of the nodule. Many of the known osteoblast-associated genes show a prominent increase in expression in the 2.3GFP pos cells as well as the total cell population, reflecting their unique activation in this highly differentiated cell population. However, other genes, the expression of which is not unique to differentiated osteoblasts, do not appear to change because they are also expressed in the 2.3GFP neg population. By day 17, the 2.3GFP neg population represents Ͼ80% of the total cell population and is likely to be composed of a heterogeneous mixture of cells from different lineages at different levels of development. Until the contribution of each cell type can be distinguished, interpretation of RNA expression from 2.3GFP neg cells will be difficult. Based on data from isolated populations, RNA from the total cell culture cannot be used to represent a comprehensive profile of osteoblast-related genes. Instead, interpretation of the expression patterns of a mature osteoblast will be greatly improved when it is based on the subpopulation of cells highly enriched for differentiated osteoblasts.
Based on this reasoning, a cell population at the level of a mature osteoblast or osteocyte (2.3GFP pos ) has acquired a high This study did not answer whether the FACS-isolated cells from in vitro formed bone nodules have a significantly different expression profile than similarly marked cells in vivo. Although the FACS sorting can have a damaging effect on cells, the 18 -28 S RNA ratio is not altered indicating that RNA degradation is minimal. Now that it is possible to extract RNA from histological sections by laser capture microscopy, it should be possible to directly compare the expression patterns of the same population of GFP-positive cells isolated from a variety of sources to validate their utility as a marker of differentiation in vitro and in vivo. Until such a complex study is performed, the overall impression gained from this microarray study using a culture system currently considered as the most representative model of osteoblast differentiation (7) is of a population with significant cellular complexity. The power of interpretation of a microarray study is only as good as the biological system that provides the input RNA. The more complex the cellular composition of the sample, the more difficult the interpretation of the microarray study, particularly for those genes that are expressed in multiple cell types.
The lack of coincidence of Col1a1 expression and pOBCol3.6GFP activity was not an anticipated finding. Both by Northern hybridization and microarray (data not shown), the increment in Col1a1 mRNA levels between the GFP-negative and -positive populations was not significant. The explanation for this discrepancy is the truncated structure of the Col1a1 promoter fragments that lack all the regulatory elements necessary to mimic the endogenous gene and possibly the integration site of the transgene. Their use as a lineage marker gene relies on the association of GFP expression in multiple transgenic mouse lines with biological criteria of developmental status. Because the expression pattern in the mouse line used in this study has remained stable over 20 generations, we believe that the marker qualities of the GFP can be relied upon to identify a consistent population of cell within the lineage.
The eventual goal of a microarray study as applied to the osteoprogenitor lineage is to define the genes that control or respond to the signals that drive the differentiation process. Presumably, abnormalities in the expression or function of these genes ultimately result in altered bone mass and will be regarded as osteoporosis risk genes. Great care in interpreting RNA-based experiments needs to be applied when osteoblast differentiation is impaired. Changes in gene expression may reflect the effect of the underlying gene mutation or the cellular composition of the model system. The two possibilities can be distinguished only when the complexity of the cell population is recognized and the analysis is performed on the isolated subpopulation.
